Loading organizations...
§ Private Profile · New Haven, CT, USA
AI medical imaging software company developing DL Precise™ to enhance breast cancer detection and tumor visualization in dense breast tissue.
DeepLook Medical is a New Haven, Connecticut-based healthcare technology company that develops artificial intelligence-powered imaging software to enhance tumor visualization and improve breast cancer detection. The company's primary FDA-cleared platform, DL Precise, utilizes proprietary shape-recognition technology to provide one-click lesion segmentation across various medical imaging modalities, specifically targeting diagnostics in dense breast tissue. Operating with a workforce of fewer than 25 employees, the firm integrates its diagnostic tools directly into existing clinical workflows to assist radiologists, healthcare providers, and oncology specialists in accurate treatment planning. DeepLook Medical generates approximately $9.4 million in annual revenue and has raised $1.7 million in early-stage funding from a syndicate of institutional backers including Connecticut Innovations, Tidal River, Angel Investor Forum, and Werth Ventures. The medical software organization was founded in 2019 and is currently led by Chief Executive Officer Marissa Fayer.
DeepLook Medical has raised $1.7M across 1 funding round.
DeepLook Medical has raised $1.7M in total across 1 funding round.
DeepLook Medical has raised $1.7M in total across 1 funding round.
DeepLook Medical's investors include Angel Investor Forum, Connecticut Innovations, OKG Capital, Tidal River, Werth Family Investment Associates.
DeepLook Medical has raised $1.7M across 1 funding round. Most recently, it raised $1.7M Other Equity in February 2024.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 8, 2024 | $1.7M Venture Round | — | Angel Investor Forum, Connecticut Innovations, OKG Capital, Tidal River, Werth Family Investment Associates | Announced |